Pasithea Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 14,457 | 1.14% |
| Individual Insiders | 111,190 | 8.78% |
| VC/PE Firms | 130,434 | 10.3% |
| General Public | 1,010,346 | 79.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 130,434 | US$404.3k | 0% | no data | |||
| 66,358 | US$205.7k | 0% | no data | |||
| 38,832 | US$120.4k | 0% | no data | |||
| 6,567 | US$20.4k | 17,200% | no data | |||
| 5,371 | US$16.7k | -4.5% | no data | |||
| 3,500 | US$10.9k | 0% | no data | |||
| 2,500 | US$7.8k | 0% | no data | |||
| 1,500 | US$4.6k | 0% | no data | |||
| 601 | US$1.9k | -66.7% | no data | |||
| 250 | US$775.0 | 0% | no data | |||
| 150 | US$464.8 | 0% | no data | |||
| 18 | US$55.7 | 200% | no data |